How Has the Approach to CLL Treatment Changed With New Medicines? Inhibitors and targeted therapies have changed the landscape of CLL treatment, so what can patients expect from modern medicine? Dr. Jeff Sharman talks about their design, capability and potential for drug resistance while using them. Get email alerts | Subscribe on YouTube | Like on Facebook | Follow on Twitter | Follow on Google+ |